Reward Sensitivity and Pharmacotherapy for Smoking Cessation

NCT02162849 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

204

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Use Cessation

Interventions

DRUG: Varenicline
DRUG: Nicotine Patch
DRUG: Placebo Patch
DRUG: Placebo Tablet
BEHAVIORAL: Questionnaires
BEHAVIORAL: Counseling Sessions
OTHER: Lab Session
OTHER: Saliva Test

Sponsor

M.D. Anderson Cancer Center

Collaborators

NAL PHARMA
Pfizer